Valor de la determinación de la fracción N-terminal del péptido natriurético tipo B en pacientes con enfermedad renal crónica

Vigil-Escalera Díaz, María; Muñiz Albaiceta, Guillermo; Martín Fernández, María.
Med. clín (Ed. impr.) ; 152(3): e13-e14, feb. 2019. tab
Artículo en Español | IBECS (España) | ID: ibc-181875

Documentos relacionados

  1. Global perspective of kidney diseases: Challenges and changes.
  2. Predicting outcomes in chronic kidney disease: needs and preferences of patients and nephrologists.
  3. Quality of Life Is Associated with Cardiac Biomarkers, Echocardiographic Indices, and Mortality in CKD Stage 4-5 Patients Not on Dialysis.
  4. Chronic Kidney Disease: Underlying Molecular Mechanisms-A Special Issue Overview.
  5. Evaluation of eGFR methods in a sub-Saharan African community-based pediatric population.
  6. Bayesian mixed model analysis uncovered 21 risk loci for chronic kidney disease in boxer dogs.
  7. The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally.
  8. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD.
  9. Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?
  10. Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes.